Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Randal H. Henderson"'
Autor:
Michael S. Rutenberg, MD, PhD, Bradford S. Hoppe, MD, MPH, Jason S. Starr, DO, Ziad Awad, MD, Mathew Thomas, MBBS, MD, Christopher G. Morris, MS, Perry Johnson, PhD, Randal H. Henderson, MD, MBA, Jeremy C. Jones, MD, Bharatsinh Gharia, MBBS, MD, Steven Bowers, MD, Herbert C. Wolfsen, MD, Sunil Krishnan, MBBS, MD, Stephen J. Ko, MD, Hani M. Babiker, MD, Romaine C. Nichols, Jr, MD
Publikováno v:
International Journal of Particle Therapy, Pp 18-29 (2022)
Purpose: When treating esophageal cancer with radiation therapy, it is critical to limit the dose to surrounding structures, such as the lung and/or heart, as much as possible. Proton radiation therapy allows a reduced radiation dose to both the hear
Externí odkaz:
https://doaj.org/article/6e0ce34c85cc410c8a3e146ab69d68ad
Autor:
Natalie A. Lockney, MD, Randal H. Henderson, MD, MBA, Steven G. Swarts, PhD, Zhenhuan Zhang, MD, PhD, Bingrong Zhang, DVM, MD, Jennifer Li, BS, Robert A. Zlotecki, MD, PhD, Christopher G. Morris, MS, Katherine A. Casey-Sawicki, MA, Paul G. Okunieff, MD
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 3, Pp 28-35 (2021)
Background: After radiation therapy (RT), circulating plasma cell-free DNA (cfDNA) released in response to RT damage to tissue can be measured within hours. We examined for a correlation between cfDNA measured during the first week of therapy and ear
Externí odkaz:
https://doaj.org/article/6f789986096b4d19b2261b3f95ebd1cd
Autor:
William M. Mendenhall, MD, Eric D. Brooks, MD, MHS, Stephanie Smith, Christopher G. Morris, MS, Curtis B. Bryant, MD, MPH, Randal H. Henderson, MD, Romaine C. Nichols, Jr., MD, Kathy McIntyre, Stuart L. Klein, MHA, Nancy P. Mendenhall, MD
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 3, Pp 36-42 (2021)
Purpose: To determine factors that influence insurance approval for definitive proton therapy (PT) for prostate cancer. Materials and Methods: Between 2014 and 2018, 1592 insured patients with localized prostate cancer were evaluated and recommended
Externí odkaz:
https://doaj.org/article/d56f508053b54ed0882190767981a28b
Autor:
Curtis M. Bryant, MD, MPH, Randal H. Henderson, MD, MBA, R. Charles Nichols, MD, William M. Mendenhall, MD, Bradford S. Hoppe, MD, MPH, Carlos E. Vargas, MD, Thomas B. Daniels, MD, C. Richard Choo, MD, Rahul R. Parikh, MD, Huan Giap, MD, PhD, Jerry D. Slater, MD, Neha Vapiwala, MD, William Barrett, MD, Akash Nanda, MD, PhD, Mark V. Mishra, MD, Seungtaek Choi, MD, Jay J. Liao, MD, Nancy P. Mendenhall, MD, the Genitourinary Subcommittee of the Particle Therapy Co-Operative Group
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 2, Pp 1-16 (2021)
Proton therapy is a promising but controversial treatment in the management of prostate cancer. Despite its dosimetric advantages when compared with photon radiation therapy, its increased cost to patients and insurers has raised questions regarding
Externí odkaz:
https://doaj.org/article/871926a9f47046e99a4987b232eaa487
Autor:
Shivam M. Kharod, MD, Catherine E. Mercado, MD, Christopher G. Morris, MS, Curtis M. Bryant, MD, MPH, Nancy P. Mendenhall, MD, William M. Mendenhall, MD, R. Charles Nichols, MD, Bradford S. Hoppe, MD, MPH, Xiaoying Liang, PhD, Zhong Su, PhD, Zuofeng Li, DSc, Randal H. Henderson, MD, MBA
Publikováno v:
International Journal of Particle Therapy, Vol 7, Iss 4, Pp 52-64 (2021)
Purpose: Postprostatectomy radiation improves disease control, but limited data exist regarding outcomes, toxicities, and patient-reported quality of life with proton therapy. Method and Materials: The first 102 patients who were enrolled on an outco
Externí odkaz:
https://doaj.org/article/8f335a2fb6b5444383014baf7ca5424e
Autor:
Shivam M. Kharod, MD, R.Charles Nichols, MD, Randal H. Henderson, MD, MBA, Christopher G. Morris, MS, Dat C. Pham, MD, Vandana K. Seeram, MBBS, Lisa M. Jones, MD, Maria Antonio-Miranda, MD, Daniel A. Siragusa, MD, Zuofeng Li, DSc, Stella Flampouri, PhD, MSc, Bradford S. Hoppe, MD, MPH
Publikováno v:
International Journal of Particle Therapy, Vol 7, Iss 2, Pp 1-10 (2020)
Purpose: Due to the excellent outcomes with image-guided stereotactic body radiotherapy for patients with early-stage non–small cell lung cancer (NSCLC) and the low treatment-related toxicities using proton therapy (PT), we investigated treatment o
Externí odkaz:
https://doaj.org/article/be204a5aa19b43449b4e30ecf3ffe4a1
Autor:
Randal H. Henderson, Curtis Bryant, R. Charles Nichols, William M. Mendenhall, Nancy P. Mendenhall
Publikováno v:
The Prostate.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::443ce0a9f2caf62083c5db575b9bea86
https://doi.org/10.1002/pros.24551
https://doi.org/10.1002/pros.24551
Autor:
Randal H. Henderson, Romaine C. Nichols, Curtis B. Bryant, William M. Mendenhall, Nancy P. Mendenhall, Christopher G. Morris, Stephanie Smith, Kathy McIntyre, Stuart L. Klein, Eric Brooks
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 3, Pp 36-42 (2021)
International Journal of Particle Therapy
International Journal of Particle Therapy
Purpose To determine factors that influence insurance approval for definitive proton therapy (PT) for prostate cancer. Materials and Methods Between 2014 and 2018, 1592 insured patients with localized prostate cancer were evaluated and recommended to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5ee017d8789fe6d3a5325062c9ef9ad
https://doi.org/10.14338/ijpt-21-00002.1
https://doi.org/10.14338/ijpt-21-00002.1
Autor:
Steven Swarts, Katherine Casey-Sawicki, Paul Okunieff, Natalie A. Lockney, Robert A. Zlotecki, Zhenhuan Zhang, Bingrong Zhang, C.G. Morris, Randal H. Henderson, Jennifer W Li
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 3, Pp 28-35 (2021)
International Journal of Particle Therapy
International Journal of Particle Therapy
Background After radiation therapy (RT), circulating plasma cell-free DNA (cfDNA) released in response to RT damage to tissue can be measured within hours. We examined for a correlation between cfDNA measured during the first week of therapy and earl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9167d92300842bb7b2d2b4401eb87592
https://theijpt.org/doi/pdf/10.14338/IJPT-D-21-00008
https://theijpt.org/doi/pdf/10.14338/IJPT-D-21-00008
Autor:
Eric M. Horwitz, Bradley J. Stish, Randal H. Henderson, Amardeep S. Grewal, Brian J. Davis, Rahul D. Tendulkar, Joseph K. Salama, Elizabeth Handorf, David Carpenter, Neha Vapiwala, Nancy P. Mendenhall, Jonathan J. Paly, Devon J. Godfrey, J. Karen Wong, Carlos Vargas
Publikováno v:
Int J Radiat Oncol Biol Phys
Purpose Data comparing moderately hypofractionated intensity modulated radiation therapy (IMRT) and proton beam therapy (PBT) are lacking. We aim to compare late toxicity profiles of patients with early-stage prostate cancer treated with moderately h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a48e089df04a56a9b008ee911e8df844
https://doi.org/10.1016/j.ijrobp.2021.01.043
https://doi.org/10.1016/j.ijrobp.2021.01.043